14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.20 $2.20 Friday, 4th Nov 2022 CRTX stock ended at $2.20. During the day the stock fluctuated 0% from a day low at $2.20 to a day high of $2.20.
90 days $2.07 $2.70
52 weeks $1.78 $17.98

Historical Cortexyme Inc. prices

Date Open High Low Close Volume
Nov 04, 2022 $2.20 $2.20 $2.20 $2.20 0
Nov 03, 2022 $2.20 $2.20 $2.20 $2.20 0
Nov 02, 2022 $2.20 $2.20 $2.20 $2.20 0
Nov 01, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 31, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 28, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 27, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 26, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 25, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 24, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 21, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 20, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 19, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 18, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 17, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 14, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 13, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 12, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 11, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 10, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 07, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 06, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 05, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 04, 2022 $2.20 $2.20 $2.20 $2.20 0
Oct 03, 2022 $2.20 $2.20 $2.20 $2.20 0
Click to get the best stock tips daily for free!

About Cortexyme Inc.

Cortexyme. Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis... CRTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT